Omni-stat Medical

Omni-stat Medical is a private medical device company focused on hemostatic products for rapid control of external bleeding in hospital and acute care settings. The company markets chitosan-based topical hemostatic products, including OMNI-STAT gauze and CELOX Vascular, for use across trauma, emergency medicine, surgery, vascular access, and wound care. Its products are designed to work quickly and to support bleeding control even in challenging clinical environments, including vascular access procedures. Omni-stat Medical operates as a subsidiary of Medtrade Products and appears to be commercially active in the United States. In 2025, the company announced a U.S. acute-care commercialization partnership with Eloquest Healthcare to expand access to its hemostatic portfolio.